Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9578 posts found.

Lilly building

Eli Lilly predicts revenue growth in 2016

January 5, 2016 Research and Development, Sales and Marketing Eli Lilly, financial reports, marketing, sales

Eli Lilly has set out its financial guidance for 2016, predicting an increase in sales to between $20.2 and $20.7 …
News
david_pyott

BioMarin elects former Allergan CEO to board

January 5, 2016 Medical Communications, Research and Development, Sales and Marketing

BioMarin Pharmaceutical has announced the election of former Allergan chief executive, David Pyott, to the company’s board of directors. Pyott served …
Appointment
Baxalta logo

Bayer and Baxalta in separate €1 billion-plus deals

January 5, 2016 Manufacturing and Production, Research and Development, Sales and Marketing Ascensia diabetes care, Baxalta, Bayer, diabetes, panasonic, symphogen

Baxalta has signed a deal with Symphogen potentially worth as much as €1.4 billion, under which the companies will develop …
News
Ovarian cancer

Pfizer, Merck and Syndax in ovarian cancer trial collaboration

January 5, 2016 Manufacturing and Production, Research and Development Merck, Pfizer, Syndax Pharmaceuticals, avelumab, entinostat, ovarian cancer

Pfizer, Merck and Syndax Pharmaceuticals have announced a collaboration to test avelumab, in combination with Syndax’s entinostat, in patients with …
News
AS spine fusion

Novartis’ Cosentyx shows benefits in Phase III AS trials

January 4, 2016 Research and Development, Sales and Marketing Cosentyx, Novartis, Secukinumab, ankylosing spondylitis

Novartis says results from two Phase III studies for Cosentyx in ankylosing spondylitis (AS) showing significant clinical improvements versus placebo.Results …
News
redx

Former Merck R&D expert joins RedX Pharma board

January 4, 2016 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing RedX Pharma

Dr Bernhard Kirschbaum, 57, has been added as a non-executive director at RedX Pharma with immediate effect. Kirschbaum is a …
Appointment
Ebola virus

WHO to review MSD’s Ebola vaccine for emergency use

December 24, 2015 Manufacturing and Production, Research and Development Ebola vaccine, Ebola virus, MSD, WHO, Zebov

The World Health Organisation (WHO) has accepted MSD’s application for the company’s investigational Ebola vaccine, V920 (Zebov), to be reviewed …
News
2016

Seven pharma trends for 2016

December 24, 2015 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing M&A, MA, biosimilars, collaborations, digital pharma, emerging markets, patient centricity, pharma, pricing

What will be the key industry trends in 2016?Pricing pressures
Feature
Celgene logo

Celgene settles Revlimid patent dispute

December 23, 2015 Manufacturing and Production, Research and Development, Sales and Marketing Celgene, India, Natco, Revlimid, lenalidomide, patents

Celgene has settled its litigation with Natco Pharma, over the patents for Revlimid, opening the door to increased generic competition …
News
melanoma cell

100 year old chemical could be the future of cancer treatment

December 23, 2015 Research and Development Cancer, PV-10, Peter Culpepper, Provectus, Rose Bengal, oncology

Peter Culpepper, chief operating officer at Provectus Biopharmaceuticals, explains the secrets of Rose Bengal, which has impressed in clinical trials …
Feature
Nucala

Researchers question price of GSK’s Nucala

December 23, 2015 Research and Development GSK, HEOR, ICER, Nucala, asthma, cost-effective, health economics, health economics outcomes research

GSK is charging up to four times more for its recently approved asthma drug Nucala than is justified by cost-effectiveness …
News
Bavarian Nordic logo

Janssen and Bavarian Nordic to collaborate on HPV vaccine

December 23, 2015 Research and Development Bavarian Nordic, HPV, Janssen, Vaccine, human papillomavirus, prime boost

Janssen has announced a new collaboration and license agreement with Bavarian Nordic to develop a vaccine for chronic Human Papillomavirus …
News
CT scan

Merck and Pfizer kick off Phase III avelumab cancer trials

December 23, 2015 Research and Development Merck, Pfizer, avelumab, ovarian cancer

Merck and Pfizer have announced the opening of trial sites for an international Phase III study of avelumab in patients …
News
Actelion building

Actelion ready to launch Uptravi after FDA approval

December 22, 2015 Research and Development, Sales and Marketing Actelion, FDA, Jean-Paul Clozel, Uptravi, pulmonary arterial hypertension, selexipag

Actelion says it is ready to launch Uptravi, its drug for pulmonary arterial hypertension in the US in January, after …
News
Flemming Ornskov

Shire moves to seal Baxalta deal with improved offer

December 22, 2015 Research and Development, Sales and Marketing Baxalta, Flemming Ornskov, Shire

Shire is set to sweeten its $30 billion bid for Baxalta by offering 40% of the total, or $12 billion, …
News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026